Scout | Deciphering the Impact of RNA Modifications on Brain Aging and AD/ADRD (R21 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Deciphering the Impact of RNA Modifications on Brain Aging and AD/ADRD (R21 Clinical Trial Not Allowed)

This grant opportunity aims to support innovative research on how RNA modifications affect brain aging and diseases like Alzheimer's and related dementias, including Lewy body dementia, frontotemporal dementia, vascular cognitive impairment/dementia, and mixed dementias. Researchers are encouraged to submit exploratory and developmental grant applications focusing on the mechanisms behind RNA …

Source

Agency: National Institutes of Health

Program: SBIR

Award

Award Ceiling: $275,000

Funding Amount: $275,000

Dates

Opportunity Released: July 31, 2024

Open for Submission: July 31, 2024

Submission Deadline: November 1, 2024

Application Window Closes: November 1, 2024

Keywords

RNA modifications

brain aging

Alzheimer's disease

AD-related dementias

molecular landscape

Lewy body dementia

frontotemporal dementia

vascular cognitive impairment

mixed dementias

R21 grant.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers